Log In
Print
BCIQ
Print
Print this Print this
 

hydrocodone bitartrate (Zohydro ER) (ZX002)

  Manage Alerts
Collapse Summary General Information
Company Pernix Therapeutics Holdings Inc.
DescriptionOral controlled-release formulation of hydrocodone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat moderate to severe chronic pain
Regulatory Designation U.S. - Undisclosed Review (Treat moderate to severe chronic pain)
Partner Alkermes plc; Endo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$393.5M

$35.8M

$288.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today